Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda

Showing 9 posts of 249 posts found.

NICE rejects Takeda cancer drug over price concerns

July 12, 2010
Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer

UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …

News

Frank Morich and Haruhiko Hirate join Takeda

June 30, 2010
Sales and Marketing Takeda, appointment, sales and marketing

Takeda has made new two appointments, looking outside the company to fill a brace of executive-level positions. Dr Frank Morich …

Appointment

Takeda appoints Kiyohiko Tamura

May 25, 2010
Sales and Marketing Takeda, appointment, sales and marketing

Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO. …

Appointment

Takeda plans cuts, eyes mergers

May 17, 2010
Research and Development, Sales and Marketing Takeda, job cuts

Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …

News

Takeda delays diabetes drug in Europe

June 4, 2009
Research and Development, Sales and Marketing Takeda, diabetes

Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …

News

Takeda to market new bone cancer drug

May 20, 2009
Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

News

Takeda chooses US base for its global development headquarters

April 2, 2009
Research and Development Takeda

Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …

News

NHS is behind us, says rep-free Takeda

March 1, 2005
Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …

News

Takeda to launch ‘radically different’ approach to NHS

July 2, 2004
NHS, Takeda, salesforce

 Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026